3 Kunnskapsstatus og forskning omkring forholdet mellom influensavaksinen Pandemrix og utvikling av søvnsykdommen narkolepsi – Referanser:
Report from an epidemiological study in Sweden on vaccination with Pandemrix and narcolepsy(http://www.lakemedelsverket.se/upload/nyheter/2011/Fallinventeringsrapport_pandermrix_110630.pdf)
A registry based comparative cohort study in four Swedish counties of the risk for narcolepsy after vaccination with Pandemrix A first and preliminary report, by the Medical Products Agency(http://www.lakemedelsverket.se/upload/nyheter/2011/PandemrixRegReport110328.pdf).
Partinen, M., et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One. 2012;7(3):e33723. Epub 2012 Mar 28.
Nohynek, H., et al. T AS03 adjuvanted A/H1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One. 2012;7(3):e33536. Epub 2012 Mar 28.
VAESCO-rapporten: Technical report. Narcolepsy in association with pandemic influenza vaccination. A multi-country European epidemiological investigation, 2012. http://www.ecdc.europa.eu/en/Search/pages/Results.aspx?k=VAESCO%20report
Report from an epidemiological study in Ireland regarding vaccination with Pandemrix and narcolepsy. Department of Health (Ireland). 19 april 2012 http://www.ecdc.europa.eu/en/healthtopics/pandemic_preparedness/2009_pandemic_vaccines/Pages/vaccine-safety.aspx
L’Agence nationale de sécurité du médicament et des produits de santé (ANSM) Service de pharmacologie (INSERM CIC-P 0005 Pharmaco-Epidémiologie), Université Bordeaux Segalen – CHU de Bordeaux aussi Etude NarcoFlu-VF (NarcoFlu VAESCO-France) : Grippe, vaccination antigrippale et narcolepsie : contribution française à l’étude cas-témoins européenne. Août 2012 (published 20 september 2012)
Presentasjon fra Vaksinedagene 2012. Status på oppfølging av mistenkte bivirkninger etter vaksinasjon med Pandemrix, http://www.fhi.no/eway/default.aspx?pid=233&trg=MainLeft_5565&MainArea_5661=5565:0:15,1223:1:0:0:::0:0&MainLeft_5565=5544:97359::1:5569:1:::0:0
*Vaccine Adverse Event Surveillance and Communication (VAESCO) Consortium